Search

Displaying results 3431 - 3440 of 10000 in total
  1. Drug

    ORM-12741

    go.drugbank.com/drugs/DB12057
    Investigational

    ORM-12741 has been used in trials studying the basic science and treatment of Alzheimer's Disease.

    Categories: Adrenergic alpha-2 Receptor Antagonists, Heterocyclic Compounds, 2-Ring
  2. Drug

    ORG-25935

    go.drugbank.com/drugs/DB12220
    Investigational

    Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

  3. Drug

    Brilanestrant

    go.drugbank.com/drugs/DB12253
    Investigational

    ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  4. Drug

    CRS-3123

    go.drugbank.com/drugs/DB12262
    Investigational

    CRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  5. Drug

    SCY-635

    go.drugbank.com/drugs/DB12451
    Investigational

    SCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection.

  6. Drug

    Dexelvucitabine

    go.drugbank.com/drugs/DB12470
    Investigational

    Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.

    Categories: Heterocyclic Compounds, 1-Ring
  7. Drug

    PD-217014

    go.drugbank.com/drugs/DB12493
    Investigational

    PD-217,014 has been used in trials studying the treatment of Pain and Irritable Bowel Syndrome.

  8. Drug

    Seletalisib

    go.drugbank.com/drugs/DB12706
    Investigational

    Seletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  9. Drug

    NVS antibody

    go.drugbank.com/drugs/DB05312
    Experimental

    This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.

  10. Drug

    Actelion-1

    go.drugbank.com/drugs/DB05367
    Experimental

    Actelion-1 is a tissue-targeting Endothelin Receptor Antagonist that has been discovered by Actelion Pharmaceuticals.

    Synonyms: Actelion-1Categories: Endothelin A Receptor Antagonists, Endothelin B Receptor Antagonists